Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00381121 · ClinicalTrials.gov registry record
University of Michigan "Nephrology Research BioBank"
A clinical trial of Chronic Kidney Disease, sponsored by University of Michigan.
- Recruiting
- Registry status
- 420
- Enrollment target
- 1
- Study location
NCT00381121: Recruiting study of Chronic Kidney Disease, sponsored by University of Michigan.
NCT00381121 is a study of Chronic Kidney Disease that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 420 participants, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00381121, a study of Chronic Kidney Disease, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 420 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan Health System - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2006-09 |
| Est. Completion | 2030-08 |
What NCT00381121 shows while recruiting
NCT00381121 is an observational study that tracks outcomes without assigning an intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00381121 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00381121 about?
NCT00381121 is a clinical study titled "University of Michigan "Nephrology Research BioBank"". The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
What is the current status of trial NCT00381121?
This trial is currently recruiting. The enrollment target is 420 participants. The study started on 2006-09. Estimated completion is 2030-08.
What conditions does trial NCT00381121 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
Who is sponsoring clinical trial NCT00381121?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00381121 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00381121's enrollment target sits among peer trials
420 28th of 101 higher than 74 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia